JAN 18, 2016 2:32 PM PST

Blimp1 Protein Vital for Antibody Production

WRITTEN BY: Kara Marker
Two recent studies have connected protein Blimp1 to key regulation of plasma cells’ ability to produce pathogen-fighting antibodies. Without this protein, scientists estimate numerous cases of cancer and autoimmune disorders result.
 
The B lymphocyte-induced maturation protein-1, known as Blimp1, has been known by scientists to regulate development of B cells, the lymphocytes that produce plasma cells and antibodies, for about 16 years (Annual Review of Immunology). However, the recent study by scientists from the Research Institute of Molecular Pathology (IMP) in Vienna, Austria was the first to show that Blimp1 regulates over half of the genes required for plasma cell development. Their 5-year project was recently published in Nature Immunology.
 
In addition to identifying Blimp1 as a vital regulator of plasma cell development genes in mice, the team from the IMP made another novel conclusion. In addition to turning genes off, Blimp1 can also turn genes on.
 

"It regulates their mobility and migration to the bone marrow. Blimp1 is also responsible for the enormous increase in size of the endoplasmic reticulum and the strong up-regulation of antibody production in plasma cells. Humoral immunity would not be possible without Blimp1,” explained team leader from the IMP, Meinrad Busslinger, PhD.

 
Blimp1's Role in Adaptive Immunity

A complementary study also published in Nature Immunology builds on the discovery of Blimp1’s key role in plasma cell development. From the Walter and Eliza Hall Institute (WEHI) in Melbourne, Australia, scientists discovered that while plasma cells could survive without Blimp1, they were rendered essentially useless, unable to produce antibodies.
 
B cell activation and development into antibody-producing plasma cells is an extremely important event in the process of adaptive immunity. Without the production of antigen-specific cells that are sent to fight off bacteria, viruses, and other invading microorganisms, the body is unable to defend itself properly. In their study, WEHI scientists acknowledged this weakness resulting from a lack of functional Blimp1 and also discussed the potential for lymphomas, multiple myelomas, and autoimmune disorders that could occur alongside a mutation in the Blimp1 protein.
 
With these two studies, scientists now understand a monumental amount more about how plasma cells develop and produce antibodies, how this process can be disturbed, and the importance of avoiding disturbing this process.
 
To learn more about the adaptive immune response from the role of B lymphocytes and antibodies, check out this video.
 
 
Source: The Research Institute of Molecular Pathology
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
NOV 25, 2021
Immunology
Battling Bacterial Pneumonia, No Antibiotics Required
NOV 25, 2021
Battling Bacterial Pneumonia, No Antibiotics Required
Instead of flooding the body with antibiotics, what if we could program cells to fight off pathogens more effectively? T ...
DEC 21, 2021
Immunology
Shark Immune Proteins as Pandemic 'Insurance'?
DEC 21, 2021
Shark Immune Proteins as Pandemic 'Insurance'?
Sharks are incredibly hardy creatures—they've survived in marine ecosystems, often unchallenged predators, for ...
DEC 27, 2021
Cancer
Improving Immunotherapy with a Novel Nanoparticle
DEC 27, 2021
Improving Immunotherapy with a Novel Nanoparticle
Malignant pleural effusion (MPE) occurs in cancer patients experiencing a buildup of fluid and tumor cells in the pleura ...
DEC 30, 2021
Immunology
Lab-Grown Bat Guts Offer Clues on Viral Outbreak Origins
DEC 30, 2021
Lab-Grown Bat Guts Offer Clues on Viral Outbreak Origins
Bats have a notorious reputation as disease-spreaders—these fuzzy, winged creatures are said to be the source of m ...
JAN 13, 2022
Immunology
Gene Unveiled as Missing Link in Antibody Development
JAN 13, 2022
Gene Unveiled as Missing Link in Antibody Development
  Antibodies are a core part of the immune system's pathogen-fighting arsenal, defending the body against bacte ...
JAN 14, 2022
Drug Discovery & Development
Repurposing Drugs 101
JAN 14, 2022
Repurposing Drugs 101
Drug development is expensive. Taking into account costs of failed trials, the average drug costs $985 million to resear ...
Loading Comments...